Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C055987 |
20-hydroxy-5,8,11,14-eicosatetraenoic acid |
20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased activity of PLD1 protein | increases activity | 15964316
|
C494667 |
20-hydroxyeicosa-6(Z),15(Z)-dienoic acid |
20-hydroxyeicosa-6(Z),15(Z)-dienoic acid results in increased activity of PLD1 protein | increases activity | 15964316
|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of PLD1 mRNA | increases expression | 19933214
|
C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PLD1 protein | increases activity | 17427178
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PLD1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PLD1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of PLD1 mRNA | increases expression | 18648102
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PLD1 mRNA | affects expression | 16483693
|
C028617 |
aroclor 1248 |
aroclor 1248 results in increased activity of PLD1 protein | increases activity | 17427178
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of PLD1 mRNA | affects expression | 17331233
|
D001554 |
Benzene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA | affects cotreatment|increases expression | 17905399
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of PLD1 mRNA | increases expression | 17879257
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [lysophosphatidic acid results in increased activity of PLD1 protein] | decreases reaction|increases activity | 11243883
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of PLD1 mRNA | decreases expression | 20678512
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased activity of PLD1 protein | increases activity|increases expression | 17065600
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] | affects reaction|increases expression | 17065600
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA] | affects reaction|increases expression | 17065600
|
D020001 |
1-Butanol |
1-Butanol results in decreased activity of PLD1 protein | decreases activity | 16449385
|
D020001 |
1-Butanol |
[1-Butanol results in decreased activity of PLD1 protein] which affects the localization of APP protein | affects localization|decreases activity | 16449385
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 11243883
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]] | affects reaction|decreases reaction|increases phosphorylation | 11243883
|
D020001 |
1-Butanol |
[1-Butanol inhibits the reaction [PRKCA protein binds to PLD1 protein]] which results in decreased activity of PLD1 protein | affects binding|decreases activity|decreases reaction | 15652502
|
D020001 |
1-Butanol |
1-Butanol results in decreased activity of PLD1 protein | decreases activity | 18344600 15652502
|
D020001 |
1-Butanol |
1-Butanol results in decreased activity of PLD1 protein | decreases activity | 16178010
|
C018021 |
cobaltous chloride |
Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
C018021 |
cobaltous chloride |
cobaltous chloride results in increased activity of PLD1 protein | increases activity | 17640750
|
C018021 |
cobaltous chloride |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
C018021 |
cobaltous chloride |
PD 169316 inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
C018021 |
cobaltous chloride |
PLD1 protein promotes the reaction [cobaltous chloride results in increased abundance of Dinoprostone] | increases abundance|increases reaction | 17640750
|
C018021 |
cobaltous chloride |
PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | increases expression|increases reaction | 17640750
|
C018021 |
cobaltous chloride |
Reactive Oxygen Species affects the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | affects reaction|increases expression|increases reaction | 17640750
|
C018021 |
cobaltous chloride |
rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PLD1 mRNA | decreases expression | 20106945
|
D003609 |
Dactinomycin |
PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974
|
D003609 |
Dactinomycin |
PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PRKCD protein] | decreases reaction|increases cleavage | 14640974
|
D003609 |
Dactinomycin |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974
|
D003609 |
Dactinomycin |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974
|
D003609 |
Dactinomycin |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein] | increases activity|increases phosphorylation|increases reaction | 14640974
|
D003609 |
Dactinomycin |
PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974
|
C117975 |
DDMS |
DDMS results in increased activity of PLD1 protein | increases activity | 15964316
|
C017180 |
decamethrin |
decamethrin results in decreased expression of PLD1 mRNA | decreases expression | 19017407
|
C014347 |
decitabine |
decitabine affects the expression of PLD1 mRNA | affects expression | 17145863
|
D019794 |
2,3-Diphosphoglycerate |
2,3-Diphosphoglycerate results in decreased activity of PLD1 protein | decreases activity | 16857255
|
C045651 |
epigallocatechin gallate |
PLD1 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | increases expression|increases reaction | 15210717
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLD1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of PLD1 mRNA | increases expression | 19619570
|
D011345 |
Fenofibrate |
Fenofibrate inhibits the reaction [Norepinephrine results in increased activity of PLD1 protein] | decreases reaction|increases activity | 15964316
|
D011345 |
Fenofibrate |
Fenofibrate results in decreased activity of PLD1 protein | decreases activity | 15964316
|
D009240 |
N-Formylmethionine Leucyl-Phenylalanine |
PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 11427526
|
D009240 |
N-Formylmethionine Leucyl-Phenylalanine |
PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein] | affects reaction|increases activity|increases phosphorylation | 11427526
|
D009240 |
N-Formylmethionine Leucyl-Phenylalanine |
PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Reactive Oxygen Species] | affects reaction|increases abundance | 17560994
|
D019833 |
Genistein |
Genistein inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein] | decreases reaction|increases activity|increases phosphorylation | 15150437
|
C081021 |
Go 6976 |
Go 6976 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein] | decreases reaction|increases activity|increases phosphorylation | 15150437
|
D006861 |
Hydrogen Peroxide |
Genistein inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein] | decreases reaction|increases activity|increases phosphorylation | 15150437
|
D006861 |
Hydrogen Peroxide |
Go 6976 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein] | decreases reaction|increases activity|increases phosphorylation | 15150437
|
D006861 |
Hydrogen Peroxide |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of PLD1 protein | affects cotreatment|increases phosphorylation | 15150437
|
D006861 |
Hydrogen Peroxide |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of [PLD1 protein binds to PRKCA protein] | affects binding|affects cotreatment|increases phosphorylation | 15150437
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein | increases activity|increases phosphorylation | 15150437
|
D012701 |
Serotonin |
HTR2A protein affects the reaction [Serotonin results in increased activity of PLD1 protein] | affects reaction|increases activity | 18621911
|
D012701 |
Serotonin |
Ketanserin inhibits the reaction [HTR2A protein affects the reaction [Serotonin results in increased activity of PLD1 protein]] | affects reaction|decreases reaction|increases activity | 18621911
|
D012701 |
Serotonin |
PLD1 protein affects the reaction [Serotonin results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] | affects reaction|increases activity|increases phosphorylation | 18621911
|
D012701 |
Serotonin |
Serotonin results in increased activity of PLD1 protein | increases activity | 18621911
|
D007650 |
Ketanserin |
Ketanserin inhibits the reaction [HTR2A protein affects the reaction [Serotonin results in increased activity of PLD1 protein]] | affects reaction|decreases reaction|increases activity | 18621911
|
C032881 |
lysophosphatidic acid |
1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 11243883
|
C032881 |
lysophosphatidic acid |
1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein]] | affects reaction|decreases reaction|increases phosphorylation | 11243883
|
C032881 |
lysophosphatidic acid |
bisindolylmaleimide I inhibits the reaction [lysophosphatidic acid results in increased activity of PLD1 protein] | decreases reaction|increases activity | 11243883
|
C032881 |
lysophosphatidic acid |
lysophosphatidic acid results in increased activity of PLD1 protein | increases activity | 11243883
|
C032881 |
lysophosphatidic acid |
Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased activity of PLD1 protein] | decreases reaction|increases activity | 11243883
|
C032881 |
lysophosphatidic acid |
PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 11243883
|
C032881 |
lysophosphatidic acid |
PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 11243883
|
C032881 |
lysophosphatidic acid |
toxB protein, Clostridium difficile inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of PLD1 protein] | decreases reaction|increases phosphorylation | 14769825
|
D008543 |
Melanins |
[TYR protein results in decreased expression of and results in decreased activity of PLD1 protein] which results in decreased abundance of Melanins | decreases abundance|decreases activity|decreases expression | 14615486
|
D009074 |
Melanocyte-Stimulating Hormones |
Melanocyte-Stimulating Hormones results in decreased expression of and results in decreased activity of PLD1 protein | decreases activity|decreases expression | 14615486
|
C030957 |
methylmercury II |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA | affects cotreatment|increases expression | 17905399
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of PLD1 mRNA | increases expression | 17584828
|
C016599 |
mono-(2-ethylhexyl)phthalate |
mono-(2-ethylhexyl)phthalate results in increased expression of PLD1 mRNA | increases expression | 16809437
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
C433446 |
N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine |
N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine results in increased activity of PLD1 protein | increases activity | 15964316
|
D009638 |
Norepinephrine |
Fenofibrate inhibits the reaction [Norepinephrine results in increased activity of PLD1 protein] | decreases reaction|increases activity | 15964316
|
D009638 |
Norepinephrine |
Norepinephrine results in increased activity of PLD1 protein | increases activity | 15964316
|
D009638 |
Norepinephrine |
pirinixic acid inhibits the reaction [Norepinephrine results in increased activity of PLD1 protein] | decreases reaction|increases activity | 15964316
|
C408604 |
PD 169316 |
PD 169316 inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased activity of PLD1 protein] | decreases reaction|increases activity | 11243883
|
D010712 |
Phosphatidic Acids |
Phosphatidic Acids results in increased activity of PLD1 protein | increases activity | 16857255
|
D010712 |
Phosphatidic Acids |
PLD1 protein results in increased chemical synthesis of Phosphatidic Acids | increases chemical synthesis | 16178010
|
C068564 |
phosphatidylbutanol |
PLD1 protein results in increased chemical synthesis of phosphatidylbutanol | increases chemical synthesis | 14640974
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLD1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid inhibits the reaction [Norepinephrine results in increased activity of PLD1 protein] | decreases reaction|increases activity | 15964316
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased activity of PLD1 protein | decreases activity | 15964316
|
D015232 |
Dinoprostone |
PLD1 protein promotes the reaction [cobaltous chloride results in increased abundance of Dinoprostone] | increases abundance|increases reaction | 17640750
|
D017382 |
Reactive Oxygen Species |
Reactive Oxygen Species affects the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | affects reaction|increases expression|increases reaction | 17640750
|
D017382 |
Reactive Oxygen Species |
PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Reactive Oxygen Species] | affects reaction|increases abundance | 17560994
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLD1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PLD1 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PLD1 mRNA | increases expression | 19619570
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of PLD1 mRNA | increases expression | 16917069
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased activity of PLD1 protein | increases activity | 15067002
|
D013755 |
Tetradecanoylphorbol Acetate |
toxB protein, Clostridium difficile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PLD1 protein] | decreases reaction|increases phosphorylation | 14769825
|
C052342 |
topiramate |
topiramate results in increased expression of PLD1 mRNA | increases expression | 16979414
|
C031815 |
toxB protein, Clostridium difficile |
toxB protein, Clostridium difficile inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of PLD1 protein] | decreases reaction|increases phosphorylation | 14769825
|
C031815 |
toxB protein, Clostridium difficile |
toxB protein, Clostridium difficile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PLD1 protein] | decreases reaction|increases phosphorylation | 14769825
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PLD1 mRNA | increases expression | 16249480
|
D014241 |
Trichloroethylene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA | affects cotreatment|increases expression | 17905399
|
D014638 |
Vanadates |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of PLD1 protein | affects cotreatment|increases phosphorylation | 15150437
|
D014638 |
Vanadates |
[Hydrogen Peroxide co-treated with Vanadates] results in increased phosphorylation of [PLD1 protein binds to PRKCA protein] | affects binding|affects cotreatment|increases phosphorylation | 15150437
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.26 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.96 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.57 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
5.95 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
5.95 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
5.95 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.34 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.34 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
7.91 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
7.91 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
4.50 | 17942926 |
MESH:D000437 |
Alcoholism |
|
topiramate |
4.55 | 18552399 17925516 19331489 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.13 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.43 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.90 | 11369114 17661222 14761424 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.03 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
10.04 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
10.04 | 10388637 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.69 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.10 | 16292516 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
4.48 | 16516891 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.48 | 16456186 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.03 | 7820390 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
3.12 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
3.12 | 18405062 8570775 18361446 15132762 19221690 18062943 17157402 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
4.48 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.83 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.15 | 15976003 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.41 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
12.15 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.15 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
12.15 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.18 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.36 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.62 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
4.93 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.33 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
4.88 | 8112388 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
5.00 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.00 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
5.00 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
5.00 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.00 | 16675129 17261762 18497071 17289903 19861407 12948864 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
5.00 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.00 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.00 | 16443354 16873071 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
5.00 | 15986119 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.99 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.86 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.32 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.55 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
9.65 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.65 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
9.65 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
9.65 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
9.65 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
9.65 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.39 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.36 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
12.00 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
12.00 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
12.00 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
12.00 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.00 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
marker/mechanism |
|
| 15988127 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
5.98 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.98 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.09 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.09 | 16936243 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
4.94 | 8216760 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.72 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
20.79 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
20.79 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
20.79 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.79 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
20.79 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.79 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.99 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
6.09 | 21254450 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
topiramate |
6.09 | 15650499 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.65 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
10.73 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
10.73 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
10.73 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.55 | 16461808 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.08 | 17157402 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.80 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.80 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.12 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.40 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.40 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.55 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
6.37 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
decamethrin |
6.37 | 19861644 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Reactive Oxygen Species |
6.37 | 15736158 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.37 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.37 | 9224671 9664655 9142499 14991402 9211117 17551590 9125849 10589399 16925845 8800419 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.95 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.95 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.86 | 19747007 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.18 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.39 | 14531868 8970840 8156756 11298694 18759878 11906362 12868966 2524372 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
5.39 | 16823706 11298694 15059100 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.12 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.94 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
8.76 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
8.76 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
8.76 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
topiramate |
8.76 | 16979414 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
2.90 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
7.08 | 11488427 7237001 10446763 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
7.08 | 10446763 11488427 8112388 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
15.23 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
15.23 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
15.23 | 9653073 18289764 18692083 9328219 9022650 1440618 16192314 8291058 7440962 11289319 18648102 6482804 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
15.23 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.23 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
15.23 | 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
15.23 | 7120509 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.31 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
3.98 | 16707586 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
16.06 | 8273558 |
MESH:D004487 |
Edema |
|
pirinixic acid |
16.06 | 12083418 |
MESH:D004487 |
Edema |
|
Serotonin |
16.06 | 18841975 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
16.06 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
16.06 | 11698051 8273558 16716910 9599246 8113982 15177302 7812673 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.91 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.91 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.50 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
3.99 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
14.43 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
14.43 | 16569247 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
14.43 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
14.43 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
7.41 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.41 | 9294722 10568697 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
6.55 | 821787 |
MESH:D004827 |
Epilepsy |
|
topiramate |
6.55 | 19148780 |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
topiramate |
5.66 | 16499746 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.71 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.71 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.30 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.30 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
10.07 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
10.07 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
10.07 | 16917069 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.87 | 11858732 |
MESH:D005334 |
Fever |
|
Dinoprostone |
4.35 | 16997862 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.41 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
11.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
11.35 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
11.35 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.62 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
5.84 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
5.84 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.48 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.98 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
6.42 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.42 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.55 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.06 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.06 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.06 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.15 | 20558911 |
MESH:D018883 |
Heat Stroke |
|
Ketanserin |
6.56 | 16205318 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.10 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.82 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.80 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
2.95 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.33 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.33 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.42 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.14 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.43 | 16354765 18606429 8697196 16959395 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
6.70 | 16793879 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.70 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.98 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.66 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.35 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
7.04 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.04 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.04 | 18670907 18850075 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
4.44 | 6740701 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
2.79 | 17581917 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
6.58 | 8273558 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
6.58 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
6.58 | 8273558 15177302 7562506 11698051 7812673 |
MESH:D007299 |
Insect Bites and Stings |
|
decamethrin |
5.18 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
9.91 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
9.91 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
9.91 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.18 | 17994277 |
MESH:D002532 |
Intracranial Aneurysm |
|
Reactive Oxygen Species |
4.46 | 19381132 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.41 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.14 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.14 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.83 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
4.70 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
4.70 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
3.73 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
18.11 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
18.11 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
18.11 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
18.11 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
18.11 | 15610895 |
MESH:D007938 |
Leukemia |
|
Benzene |
12.24 | 18335105 14694614 15935818 17119257 |
MESH:D007938 |
Leukemia |
|
decitabine |
12.24 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
12.24 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
12.24 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
12.96 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
12.96 | 17236224 19117987 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
12.96 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
5.35 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.35 | 18704418 17679729 18206229 18460780 19010910 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.35 | 19850784 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.85 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.74 | 16331271 17217047 9834237 17294898 16766008 12679006 17368321 19029980 19642359 16140955 16891316 16823087 15748426 16935935 19035177 17301526 17712046 17506722 17107899 16788101 17361223 17649720 19075265 19225113 17339181 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.86 | 9224671 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.80 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
11.36 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
11.36 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
11.36 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
11.36 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
11.36 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
11.36 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
11.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
11.36 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
3.30 | 15816358 |
MESH:D008113 |
Liver Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
14.47 | 16835634 18644402 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.47 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.47 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
14.47 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.47 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.47 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
18.21 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
18.21 | 6587162 598648 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
18.21 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
18.21 | 18775883 18253720 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
18.21 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
18.21 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
3.63 | 12815614 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.20 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.45 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
4.10 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.10 | 20869020 18520028 18569708 20464547 20135361 18816296 20064080 17053015 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.10 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
4.10 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Benzene |
6.35 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
decitabine |
6.35 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
3.85 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
10.99 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.99 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
10.99 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
10.99 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.87 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.51 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
6.22 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
6.22 | 17992120 11746506 |
MESH:D008545 |
Melanoma |
|
Reactive Oxygen Species |
6.22 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
6.22 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.84 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
2.91 | 18303189 16966607 16166281 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.17 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
topiramate |
4.14 | 18759728 16942474 18803445 18765137 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
4.69 | 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.72 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
6.11 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
6.11 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
4.89 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.92 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
6.23 | 19010910 16882708 19157545 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.23 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
4.72 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
4.72 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.54 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.49 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.49 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
16.49 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.49 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.36 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.36 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.14 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
5.14 | 14720322 |
MESH:D009369 |
Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
15.48 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
15.48 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
15.48 | 19470736 17925555 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
15.48 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
15.48 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
15.48 | 11911487 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.14 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.18 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.83 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.77 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
24.71 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
24.71 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
24.71 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
24.71 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
24.71 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
14.00 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
14.00 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
14.00 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
14.00 | 9142499 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.64 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
17.30 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
17.30 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
17.30 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
17.30 | 17119257 15612468 17479406 15935809 15576619 15913788 16737584 15727169 17178637 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.41 | 3988306 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
5.86 | 18500342 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.86 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.53 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.39 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
15.83 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
15.83 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
15.83 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
15.83 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
15.83 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
15.83 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.43 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
10.29 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Reactive Oxygen Species |
10.29 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
10.29 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
10.29 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
12.25 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
12.25 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
12.25 | 12065085 18922899 8330346 18404319 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.63 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
4.82 | 11026799 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.86 | 6228378 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.31 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.99 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.71 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
7.52 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.52 | 11222880 11896295 11399792 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.14 | 17616702 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
4.81 | 10903871 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.75 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.75 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.24 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.24 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.24 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.24 | 16925846 15256057 15378649 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.05 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.99 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.19 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.18 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.77 | 15814490 17365031 17975199 17322281 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.06 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
3.98 | 12210543 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.26 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.92 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.10 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.10 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
4.51 | 14601052 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
7.54 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
7.54 | 18551238 |
MESH:D012640 |
Seizures |
|
topiramate |
7.54 | 16499746 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
14.53 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
14.53 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.53 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.53 | 11807781 12065085 8985016 8330346 18404319 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
14.53 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
4.07 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.07 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.07 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.07 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
3.48 | 17918041 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.39 | 16684133 16045194 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
4.86 | 3261545 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.36 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.29 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.30 | 7505956 6582329 3712494 1399818 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
9.30 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
9.30 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.07 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.26 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.83 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.84 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.84 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.84 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.84 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.84 | 19087683 17616700 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.99 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.99 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.15 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.39 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
3.77 | 12562636 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.79 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.79 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.37 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.98 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.49 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.63 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.45 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
lysophosphatidic acid |
4.81 | 15541073 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.83 | 17120751 |